Endymed Ltd (ENDY.TA)
ILA 282.7
(-2.75%)
ILA 282.7
(-2.75%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 10.66 Million USD | 23.84% |
| 2022 | 8.61 Million USD | 20.78% |
| 2021 | 7.13 Million USD | 0.98% |
| 2020 | 7.06 Million USD | -10.72% |
| 2019 | 7.91 Million USD | 0.18% |
| 2018 | 7.89 Million ILS | -21.63% |
| 2017 | 10.07 Million ILS | -5.34% |
| 2016 | 10.64 Million ILS | 6.9% |
| 2015 | 9.95 Million USD | 92.22% |
| 2014 | 5.18 Million USD | 33.36% |
| 2013 | 3.88 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 2.62 Million USD | -1.87% |
| 2024 Q1 | 2.67 Million USD | 3.13% |
| 2023 Q2 | 2.71 Million USD | 8.34% |
| 2023 Q1 | 2.5 Million USD | 10.5% |
| 2023 Q4 | 2.59 Million USD | -9.34% |
| 2023 Q3 | 2.85 Million USD | 5.31% |
| 2023 FY | 10.66 Million USD | 23.84% |
| 2022 Q3 | 2.05 Million USD | -0.1% |
| 2022 FY | 8.61 Million USD | 20.78% |
| 2022 Q4 | 2.26 Million USD | 10.16% |
| 2022 Q2 | 2.06 Million USD | -7.58% |
| 2022 Q1 | 2.22 Million USD | 7.27% |
| 2021 Q4 | 2.07 Million USD | 20.95% |
| 2021 Q1 | 1.53 Million USD | -30.22% |
| 2021 Q2 | 1.79 Million USD | 17.05% |
| 2021 FY | 7.13 Million USD | 0.98% |
| 2021 Q3 | 1.71 Million USD | -4.5% |
| 2020 Q3 | 2.2 Million USD | 58.06% |
| 2020 Q1 | 1.39 Million USD | -24.14% |
| 2020 Q2 | 1.39 Million USD | 0.0% |
| 2020 Q4 | 2.2 Million USD | 0.0% |
| 2020 FY | 7.06 Million USD | -10.72% |
| 2019 Q2 | 2.24 Million ILS | 5.45% |
| 2019 Q3 | 1.7 Million ILS | -24.03% |
| 2019 FY | 7.91 Million USD | 0.18% |
| 2019 Q4 | 1.83 Million USD | 7.81% |
| 2019 Q1 | 2.12 Million ILS | -2.92% |
| 2018 Q1 | 1.98 Million ILS | -20.6% |
| 2018 FY | 7.89 Million ILS | -21.63% |
| 2018 Q4 | 2.19 Million ILS | 24.77% |
| 2018 Q3 | 1.75 Million ILS | -10.64% |
| 2018 Q2 | 1.96 Million ILS | -1.01% |
| 2017 Q2 | 2.33 Million USD | -13.54% |
| 2017 Q3 | 2.38 Million USD | 2.14% |
| 2017 Q4 | 2.5 Million USD | 4.69% |
| 2017 FY | 10.07 Million ILS | -5.34% |
| 2017 Q1 | 2.7 Million USD | -18.41% |
| 2016 Q2 | 2.46 Million USD | -7.02% |
| 2016 Q3 | 2.37 Million USD | -3.45% |
| 2016 FY | 10.64 Million ILS | 6.9% |
| 2016 Q4 | 3.31 Million USD | 39.36% |
| 2016 Q1 | 2.64 Million USD | -21.7% |
| 2015 FY | 9.95 Million USD | 92.22% |
| 2015 Q4 | 3.38 Million USD | 48.7% |
| 2015 Q3 | 2.27 Million USD | 1.65% |
| 2015 Q2 | 2.23 Million USD | 8.48% |
| 2015 Q1 | 2.06 Million USD | 54.3% |
| 2014 Q2 | 1.45 Million USD | 15.52% |
| 2014 Q1 | 1.26 Million USD | 2.04% |
| 2014 FY | 5.18 Million USD | 33.36% |
| 2014 Q4 | 1.33 Million USD | 14.96% |
| 2014 Q3 | 1.16 Million USD | -20.29% |
| 2013 FY | 3.88 Million USD | 0.0% |
| 2013 Q2 | 952.43 Thousand USD | 9.24% |
| 2013 Q3 | 836.8 Thousand USD | -12.14% |
| 2013 Q4 | 1.23 Million USD | 47.91% |
| 2013 Q1 | 871.84 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|